Investigation Overview
April 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) was announced over potential breaches of fiduciary duties by certain officers and directors at Immune Pharmaceuticals Inc. The investigation by a law firm concerns whether certain Immune Pharmaceuticals Inc (NASDAQ:IMNP officers and directors breache...
You must register (for free) or login to view the entire investigation.